Jonathon Hull Jonathon2.Hull@uwe.ac.uk
Senior Lecturer in Biomedical Sci (Biochemistry)
Distribution of the branched-chain α-ketoacid dehydrogenase complex E1α subunit and glutamate dehydrogenase in the human brain and their role in neuro-metabolism
Hull, Jonathon; Usmari Moraes, Marcela; Brookes, Emma; Love, Seth; Conway, Myra E.
Authors
Marcela Usmari Moraes
Emma Brookes
Seth Love
Myra Conway Myra.Conway@uwe.ac.uk
Occasional Associate Lecturer - CHSS - DAS
Abstract
© 2017 Glutamate is the major excitatory neurotransmitter of the central nervous system, with the branched-chain amino acids (BCAAs) acting as key nitrogen donors for de novo glutamate synthesis. Despite the importance of these major metabolites, their metabolic pathway in the human brain is still not well characterised. The metabolic pathways that influence the metabolism of BCAAs have been well characterised in rat models. However, the expression of key proteins such as the branched-chain α-ketoacid dehydrogenase (BCKD) complex and glutamate dehydrogenase isozymes (GDH) in the human brain is still not well characterised. We have used specific antibodies to these proteins to analyse their distribution within the human brain and report, for the first time, that the E1α subunit of the BCKD is located in both neurons and vascular endothelial cells. We also demonstrate that GDH is localised to astrocytes, although vascular immunolabelling does occur. The labelling of GDH was most intense in astrocytes adjacent to the hippocampus, in keeping with glutamatergic neurotransmission in this region. GDH was also present in astrocyte processes abutting vascular endothelial cells. Previously, we demonstrated that the branched-chain aminotransferase (hBCAT) proteins were most abundant in vascular cells (hBCATm) and neurons (hBCATc). Present findings are further evidence that BCAAs are metabolised within both the vasculature and neurons in the human brain. We suggest that GDH, hBCAT and the BCKD proteins operate in conjunction with astrocytic glutamate transporters and glutamine synthetase to regulate the availability of glutamate. This has important implications given that the dysregulation of glutamate metabolism, leading to glutamate excitotoxicity, is an important contributor to the pathogenesis of several neurodegenerative conditions such as Alzheimer's disease.
Journal Article Type | Article |
---|---|
Acceptance Date | Nov 13, 2017 |
Online Publication Date | Nov 2, 2017 |
Publication Date | Jan 1, 2018 |
Deposit Date | Nov 17, 2017 |
Publicly Available Date | Nov 2, 2018 |
Journal | Neurochemistry International |
Print ISSN | 0197-0186 |
Publisher | Elsevier |
Peer Reviewed | Peer Reviewed |
Volume | 112 |
Pages | 49-58 |
DOI | https://doi.org/10.1016/j.neuint.2017.10.014 |
Keywords | BCAA, BCKD, GDH, glutamate |
Public URL | https://uwe-repository.worktribe.com/output/871871 |
Publisher URL | http://dx.doi.org/10.1016/j.neuint.2017.10.014 |
Contract Date | Nov 20, 2017 |
Files
Figures and Tables.zip
(13 Mb)
Archive
RESUBMISSION manuscript.pdf
(653 Kb)
PDF
RESUBMISSION manuscript.docx
(84 Kb)
Document
You might also like
Immunotherapeutic and pharmacological approaches for the treatment of Alzheimer’s disease
(2018)
Journal Article
Downloadable Citations
About UWE Bristol Research Repository
Administrator e-mail: repository@uwe.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search